Le sildénafil présent dans Kamagra exerce une inhibition réversible de la PDE5, modulant la cascade GMPc et favorisant une vasodilatation localisée. L’absorption digestive varie selon la forme utilisée, comprimés classiques ou gels oraux. La distribution tissulaire est large et la liaison protéique élevée, avoisinant 96 %. La métabolisation hépatique génère un métabolite actif contribuant à l’effet pharmacologique global. La demi-vie reste courte, avec disparition plasmatique en quelques heures. Les interactions significatives concernent surtout les nitrés organiques et inhibiteurs puissants du CYP3A4. Dans les publications techniques, kamagra en ligne est souvent cité dans le cadre d’analyses comparatives portant sur les différences de formulations et de cinétique d’absorption.

Microsoft word - reference list.doc

NAADAC’s Life-Long Learning Series
Blending Solutions: Integrating Motivational Interviewing with
Pharmacotherapy
Presentation References by Footnote and Section
Section One: Blending Solutions to Increase Motivation and Change
1 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller & S.
Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 2 – Project MATCH Research Group. (1993). Project MATCH: Rationale and methods for a multisite clinical trial matching
patients to alcoholism treatment. Alcoholism: Clinical and Experimental Research, 17, 1130-1145. 3 – Odyssey Pharmaceuticals, Inc. (2005). Antabuse (disulfiram, USP) [package insert]. East Hanover, NJ:
Author.;Duramed Pharmaceuticals, Inc. (2005). ReVia (naltrexone hydrochloride) [package insert]. Pomona, NY: Author.; Mallinckrodt, Inc. (2003). Depade (naltrexone hydrochloride tablets, USP) [package insert]. St. Louis, MO: Author.; Forest Pharmaceuticals, Inc. (2005). Campral (acamprosate calcium) [package insert]. St Louis, MO: Author.; Alkermes, Inc. (2006). Vivitrol (naltrexone for extended-release injectable suspension) [package insert]. Cambridge, MA: Author. 4 – Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B.M, Ritson, B., Ropner, R., et al. (1992). Disulfiram
treatment of alcoholism. British Journal of Psychiatry, 161, 84-89.; Fuller, R.K., Branchey, L., Brightwell, D.R., Derman, R.M., Emrick, C.D., Iber, F.L., et al. (1986). Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. Journal of the American Medical Association, 256(11), 1449-1455.; Garbutt, J.C., Kranzler, H.R., O’Malley, S.S., Gastfriend, D.R., Pettinati, H.M., Silverman, B.L., et al. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of American Medical Association, 203(13), 1617-1625.; O’Malley, S.S., Jaffe, A.J., Chang, G., Schottenfeld, R.S., Meyer, R.E., Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence. Archive of General Psychiatry, 49, 881-887.; Paille, F.M., Guelfi, J.D., Perkins, A.C., Royer, R.J., Steru, L., & Parot, Philippe. (1995). Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism, 30(2), 239-247.; Pelc I., Ansoms, C., Lehert, P., Fischer, F., Fuchs, W., Landron, F., et. al. (2002). The European NEAT program: An integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism: Clinical and Experimental Research, 26(10), 1529-1538.; Sass, H., Soyka, M., Mann, K., & Zieglgansberger, W. (1996). Relapse prevention by acamprosate: Results from a placebo-controlled study on alcohol dependence. Archives of General Psychiatry, 53(8), 673-680.; Volpicelli, J.R., Alterman, A.I., Hayashida, M., & O’Brien, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880. 5 – DiClemente, C.C. (2006). Natural change and the troublesome use of substances: A life-course perspective. In W.R.
Miller, K.M. Carroll (Eds.), Rethinking substance abuse: What the science shows and what we should do about it (pp. 81-96). New York: Guilford Press. 6 – DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York:
7 – DiClemente, C.C. (2006). Natural change and the troublesome use of substances: A life-course perspective. In W.R.
Miller, K.M. Carroll (Eds.), Rethinking substance abuse: What the science shows and what we should do about it (pp. 81-96). New York: Guilford Press.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 8 – DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York:
The Guilford Press.; DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller & S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 9 – Adapted from DiClemente, C.C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change in addiction
treatment. American Journal on Addictions, 13(2), 103-119. 10 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 11 – Miller, W.R. & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford Press.
12 – Miller, W.R. (2006). Motivational factors in addictive behaviors. In W.R. Miller, K.M. Carroll (Eds.), Rethinking
substance abuse: What the science shows and what we should do about it (pp. 134-151). New York: Guilford Press.; DiClemente, C.C., & Velasquez, M. (2002). Motivational interviewing and the stages of change. In W.R. Miller & S. Rollnick (Eds.), Motivational interviewing (2nd ed., pp. 201-216). New York, NY: Guilford Publications, Inc.; DiClemente, C.C., et al. (2003). Psychotherapy in alcoholism treatment. In B. Johnson, P. Ruiz, M. Galanter (Eds.), Handbook of Clinical Alcoholism Treatment (pp.102-110). Philadelphia, PA: Lippincott Williams & Wilkins. 13 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.
Section Two: Motivational Interviewing
14 thru 19 – Miller, W.R. & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York:
20 – Prochaska, J.O., Norcross, J.C., & DiClemente, C.C. (1994). Changing for good. New York: Avon Books.
21 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.
Section Three: Blending Solutions with the Stages of Change
22 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 23 and 24 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R.
Miller & S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 25 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 26 – Duramed Pharmaceuticals, Inc. (2005). ReVia (naltrexone hydrochloride) [package insert]. Pomona, NY: Author.;
Mallinckrodt, Inc. (2003). Depade (naltrexone hydrochloride tablets, USP) [package insert]. St. Louis, MO: Author.; Alkermes, Inc. (2006). Vivitrol (naltrexone for extended-release injectable suspension) [package insert]. Cambridge, MA: Author. 27 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 28 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 29 and 30 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R.
Miller & S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 31 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 32 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 33 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 34 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 35 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 36 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 37 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 38 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 39 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 40 – Duramed Pharmaceuticals, Inc. (2005). ReVia (naltrexone hydrochloride) [package insert]. Pomona, NY: Author.;
Mallinckrodt, Inc. (2003). Depade (naltrexone hydrochloride tablets, USP) [package insert]. St. Louis, MO: Author.; Alkermes, Inc. (2006). Vivitrol (naltrexone for extended-release injectable suspension) [package insert]. Cambridge, MA: Author. 41 – Alkermes, Inc. (2006). Vivitrol (naltrexone for extended-release injectable suspension) [package insert]. Cambridge,
42 – Forest Pharmaceuticals, Inc. (2005). Campral (acamprosate calcium) [package insert]. St Louis, MO: Author.
43 – Odyssey Pharmaceuticals, Inc. (2005). Antabuse (disulfiram, USP) [package insert]. East Hanover, NJ: Author.
44 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 45 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 46 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 47 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 48 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 49 – Prochaska, J.O. & DiClemente, C.C. (1984). The transtheoretical approach: Crossing traditional boundaries of
therapy. Homewood, IL: Dow Jones-Irwin.; DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York: The Guilford Press. 50 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press. 51 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 52 – Duramed Pharmaceuticals, Inc. (2005). ReVia (naltrexone hydrochloride) [package insert]. Pomona, NY: Author.;
Mallinckrodt, Inc. (2003). Depade (naltrexone hydrochloride tablets, USP) [package insert]. St. Louis, MO: Author.; Alkermes, Inc. (2006). Vivitrol (naltrexone for extended-release injectable suspension) [package insert]. Cambridge, MA: Author. 53 – Forest Pharmaceuticals, Inc. (2005). Campral (acamprosate calcium) [package insert]. St Louis, MO: Author.
54 – Odyssey Pharmaceuticals, Inc. (2005). Antabuse (disulfiram, USP) [package insert]. East Hanover, NJ: Author.
55 – DiClemente, C.C. & Velasquez, M.M. (2002). Motivational interviewing and the stages of change. In W.R. Miller &
S. Rollnick, Motivational interviewing: Preparing people for change (pp. 201-216). New York: Guilford Press.; DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical model. Journal of Addiction Nursing, 16, 5-12. 56 – DiClemente, C.C. (2005). Conceptual models and applied research: The ongoing contribution of the transtheoretical
model. Journal of Addiction Nursing, 16, 5-12. 57 – DiClemente, C.C. (2003). Addiction and change: How addictions develop and addicted people recover. New York:
58 – McCaul, M.E. & Petry, N.M. (2003). The role of psychosocial treatments in pharmacotherapy for alcoholism. The
American Journal on Addictions, 12, S41-S52.

Source: http://sample01.naadac.org/pdfs/blending_references.pdf